Could an Anti-Aging Enzyme Be the Secret to a Long Life?

In July 2020, Science Advances published research suggesting that one of the secrets to a long life is being unraveled. According to scientists, a newly discovered enzyme plays a key role in people with long life spans. Let us take a closer look together.
The secret to a long life expectancy lies in the details
At the ends of chromosomes, telomeres are special sequences. These sequences protect a person’s DNA from breaks and play important regulatory roles during cell proliferation. Telomere ends shorten with every cell division, bringing aging with them. In the new study, scientists suggest that it is possible to change this situation.
A study by researchers at the Korea Advanced Institute of Science and Technology examined the cellular energy pathway associated with longevity from a new perspective. Research in human cells and roundworms raised expectations for anti-aging approaches / drug candidates that could extend life span by activating this pathway.
AMPK (adenosine monophosphate-activated protein kinase), a protein that plays an important role in cellular metabolism, has a broad range of effects, from improving heart health to extending life span. It is activated in response to low cellular energy levels, as often occurs during exercise or periods of calorie restriction. Animal studies had shown that activating AMPK led to a considerable increase in life span.
The study discovered an enzyme that works with AMPK to regulate cellular energy processes, called VRK-1. Increasing VRK-1 activity in roundworms was found to stimulate AMPK activity and extend the organism’s life span. Suppressing the enzyme’s activity was observed to have the opposite effect.
In experiments with worms, the relevant genes were activated so that cells would produce the VRK-1 protein. The studies showed an increase in life span when the proteins involved in the worms’ cellular energy use were repaired; control-group worms lived an average of 16.9 days, whereas experimental worms with high VRK-1 activity lived an average of 20.8 days in the first experimental group and 23.7 days in the second.
Continuing their work with cellular tests, the team confirmed that a similar VRK-1/AMPK mechanism also operates in human cells. Based on this discovery, the researchers suggest that life span could be extended using drugs that alter VRK-1 activity. At the same time, for active / physically active and non-obese people the VRK-1/AMPK relationship offers a mechanistic explanation for why they live longer (see Blue Zone people).
However, more research is needed to better understand how VRK-1 activates AMPK. The mechanisms by which AMPK controls cellular energy need to be identified.
This study is a small experiment conducted in roundworms and a few human cells. It also needs to be tested in other mammals, such as mice, to prove that VRK-1 can trigger longevity through AMPK. This study appears to offer inspiration for more comprehensive studies in the future.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.